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Marc Peters-Golden4, Claudio Canetti5, Lisa J. Gould2,3,6 and Claudia F. Benjamim1,6
Lipid mediators derived from 5-lipoxygenase (5-LO) metabolism can activate both pro- and anti-inflammatory
pathways, but their role in wound healing remains largely unexplored. In this study we show that 5-LO knockout
(5-LO / ) mice exhibited faster wound healing than wild-type (WT) animals, and exhibited upregulation of heme
oxygenase-1 (HO-1). Furthermore, HO-1 inhibition in 5-LO / mice abolished the beneficial effect observed.
Despite the fact that 5-LO / mice exhibited faster healing, in in vitro assays both migration and proliferation of
human dermal fibroblasts (HDFs) were inhibited by the 5-LO pharmacologic inhibitor AA861. No changes were
observed in the expression of fibronectin, transforming growth factor (I and III), and a-smooth muscle actin
(a-SMA). Interestingly, AA861 treatment significantly decreased ROS formation by stimulated fibroblasts. Similar
to 5-LO / mice, induction of HO-1, but not superoxide dismutase-2 (SOD-2), was also observed in response to
5-LO (AA861) or 5-LO activating protein (MK886) inhibitors. HO-1 induction was independent of nuclear factor
(erythroid derived-2) like2 (Nrf-2), cyclooxygenase 2 (COX-2) products, or lipoxin action. Taken together, our
results show that 5-LO disruption improves wound healing and alters fibroblast function by an antioxidant
mechanism based on HO-1 induction. Overexpression of HO-1 in wounds may facilitate early wound resolution.
Journal of Investigative Dermatology (2014) 134, 1436–1445; doi:10.1038/jid.2013.493; published online 2 January 2014
INTRODUCTION
The inflammatory process is an important component of
the wound repair in response to tissue damage. This process
is modulated by resident cells as well as by recruited
leukocytes that are responsible for triggering the inflammatory
responses and tissue repair. However, an excessive and/or
chronic inflammation can impair wound healing owing
to exacerbated cytokine/chemokine production (Martin and
Leibovich, 2005).
Eicosanoids are among the earliest signals that are released
in response to injury. Two families of enzymes, namely, the
cyclooxygenases (COX-1 and COX-2) and the lipoxygenases
(5-LO, 12-LO, and 15-LO), metabolize arachidonic acid to
form these lipid mediators. Eicosanoids initiate, amplify, and
perpetuate inflammation, but they also act as key regulators
that promote the resolution of inflammatory response. Classi-
cally, prostaglandin E2 promotes local changes in blood flow
and hyperalgesia, cysteinyl leukotrienes (LTs) promote vascu-
lar permeability and smooth muscle contraction, and LTB4
stimulates leukocyte chemotaxis and activation (Samuelsson
et al., 1987; Flower, 2006). During an inflammatory process,
the profile of eicosanoids generated shifts to biosynthesis of
anti-inflammatory and proresolving mediators (Serhan et al.,
2000). In this scenario, mediators including lipoxin A4 (LXA4),
15-deoxy-prostaglandin J2, eicosapentaenoic acid–derived
resolvin (Rv) E1, docoahexaenoic acid–derived Rv, and
protectin D1 prevent polymorphonuclear infiltration into
inflamed tissue and stimulate their phagocytosis (efferocytosis)
by macrophages, thus promoting inflammation resolution
(Serhan et al., 2008).
The heme oxygenases (HOs) are a family of ubiquitous
enzymes that catalyze the degradation of heme to bilirubin,
producing equimolar amounts of biliverdin, free iron, and
carbon monoxide. There are three known HO isoforms: the
inducible isoform HO-1 and the constitutive isoforms HO-2
and HO-3 (Wunder and Potter, 2003). HO-1 expression is
positively modulated by a number of inflammatory mediators,
oxidative stress, and also heme itself. In contrast, HO-1 is
negatively modulated by LTB4 and LTC4 in zymosan-
stimulated macrophages (Vicente et al., 2001). In a mouse
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full-thickness excisional wound model, an increase in mRNA
and protein levels of HO-1, but not HO-2, was observed at
day 1 that decreases during the subsequent healing process
(Hanselmann et al., 2001). The role of HO-1 in wound repair
was confirmed by HO-1 / mice that have impaired wound
reepithelialization and angiogenesis, resulting in delayed
wound closure (Wagener et al., 2003).
HO-1 is commonly regarded as an anti-inflammatory and
immunosuppressive enzyme. Numerous studies have demon-
strated that this stress-responsive enzyme attenuates inflam-
mation and modulates immune responses, both in vitro and
in vivo (Alcaraz et al., 2003). Some examples of anti-
inflammatory activities of HO-1 include inhibition of
CD4þ T-cell activation and proliferation (Pae et al., 2004);
activation of CD4þCD25þ T cells (T regulatory cells)
in vitro (Choi et al., 2005); and inhibition of antigen-
presenting T cells (Listopad et al., 2007). The relationship
between 5-LO and HO-1 is not well explored in the context of
wound healing.
Reactive oxygen species (ROS) production induced by
5-LO metabolites has an important role in several inflamma-
tory responses (Cho et al., 2011). The ROS effects on
chemotaxis, phagocytosis, inflammation, cancer progression,
apoptosis, and aging are well known (Ray et al., 2012). In
this study, we demonstrate that pharmacologic or genetic
interruption of 5-LO pathway metabolites leads to HO-1
induction that, in turn, decreases ROS production and
improves wound healing.
RESULTS
To investigate the role of 5-LO metabolites in wound healing,
5-LO / mice were used for the full-thickness wound model.
5-LO / mice healed faster than wild-type (WT) animals,
with significant differences at days 3 and 7 after injury
(Figure 1a and b). All wounds were completely reepithelia-
lized by day 14. The data suggest that 5-LO products have a
detrimental role for wound healing, mainly during the inflam-
matory and granulation phases.
Leukocyte infiltration in the wound bed was reduced in
5-LO / mice compared with WT mice at days 2 and 7
(Figure 2a and b). In addition, the 5-LO / mice showed an
increased number of layers in the new epidermis compared
with WT mice at both time points analyzed. There was no
difference in total collagen deposition (picrosirius staining and
hydroxyproline assay) between 5-LO / and WT mice
(Figure 2c–e). Myofibroblasts, identified by a-smooth muscle
actin (a-SMA) expression, were present in the wound bed at
day 7 after injury; however, no difference was noted between
5-LO / and WT animals (Figure 2f and g).
HO-1 induction is necessary for efficient wound closure
and neovascularization (Grochot-Przeczek et al., 2009). We
found HO-1 expression to be upregulated at day 2 (Figure 3a
and b) and day 7 (Figure 3a and c) after injury in 5-LO /
mice compared with WT mice, suggesting that 5-LO metabo-
lites suppress HO-1 expression.
To determine whether HO-1 upregulation in 5-LO / mice
contributes to better healing, we treated the wounds with the
HO-1 inhibitor, tin protoporphyrin IX (SnPPIX). As noted in
Figure 3d and e, wound healing was delayed in the SnPPIX-
treated group as compared with the nontreated group.
Using primary cultures of human dermal fibroblasts (HDFs)
incubated with AA861, a 5-LO inhibitor, we observed a
significant reduction in the percentage of proliferating cells
in comparison with the untreated group (Figure 4a and b).
AA861 also inhibited migration of HDFs (Figure 4c and d).
Fibronectin is secreted by fibroblasts and is essential to the
wound healing process. AA861 did not affect fibronectin
production, as determined by immunofluorescence (Figure 4e)
and by western blotting (Figure 4f). Similarly, neither produc-
tion of profibrotic growth factors transforming growth factor-bI
and -bIII (Figure 4g and h, respectively) nor expression of
a-SMA (Figure 4i) was altered by AA861.
ROS production and HO-1 and superoxide dismutase 2
(SOD-2) expression were evaluated in HDFs after incubation
with AA861. AA861 prevented the ROS production induced
by hyperbaric oxygen exposure (Figure 5a). HO-1 expression,
evaluated by immunofluorescence, was located mainly in the
nuclei of HDFs. However, AA861 treatment induced HO-1
overexpression that appeared in granules in the cytoplasm
(Figure 5b). AA861 caused a dose-dependent upregulation of
HO-1 (Figure 5c and d) in HDFs, without changing SOD-2
levels (Figure 5c and e). HO-1 expression returned to basal
levels 48hours after AA861 treatment (data not shown).
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Figure 1. The 5-lipoxygenase (5-LO)-deficient mice have accelerated wound
healing. The 5-LO / mice and wild-type mice (WT) were submitted to
excisional full-thickness wound created using a 10-mm punch biopsy. The
wounds were maintained uncovered and measured at days 0, 3, 7, 10, and 14.
(a) Photos representative for each group. (b) Graph of wound areas. The area at
day 0 was considered 100%, and the subsequent areas were proportional to
the initial area. The graph represents the median with range. *Po0.05.
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Figure 2. Wound histological characterization in 5-lipoxygenase knockout (5-LO / ) mice. Wounds were harvested at days 2 and 7 after surgery.
(a) Hematoxylin and eosin (H&E) staining in wounds from wild-type (WT) and 5-LO / mice. The open squares represent the areas shown in large magnification.
(b) Leukocyte infiltration and number of cell layers in the epidermis. (c) Picrosirius staining showing total collagen in wounds from WT and 5-LO / mice at
day 7. Bar¼500mm. (d) Graph showing the mean fluorescence intensity (MFI) of total collagen in all slides analyzed. (e) Hydroxyproline (OH-proline) content in
wound tissue at day 7. (f) Immunofluorescence for a-smooth muscle actin (a-SMA) in wounds from WT and 5-LO / mice at day 7. Bar¼100mm. (g) Graph
showing the MFI of a-SMA expression. For collagen and a-SMA quantification, 3 fields per slide and 5 slides per group were analyzed (a total of 15 analyses
per group). NE, new epidermis.
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Similar results were observed with MK886, an inhibitor of
5-LO-activating protein (Figure 5f).
To understand the mechanism involved in HO-1 upregula-
tion caused by 5-LO inhibition, we assessed Nrf2 (nuclear
factor (erythroid derived-2) like 2) expression and activation.
Nrf2 is the main transcription factor that induces the expres-
sion of HO-1 and other antioxidant enzymes. Data in
Figure 6a show that Nrf2 expression was not altered by
AA861 at 24hours. Next, Nrf2 activation (p-Nrf2) was
evaluated at different time points after AA861 treatment. As
observed in Figure 6b–j, p-Nrf2 levels remained unaltered at
all time points analyzed, whereas HO-1 was upregulated.
These results suggest that HO-1 induction by 5-LO inhibition
occurs in an Nrf2-independent manner.
To exclude the possibility that HO-1 expression was due to
COX metabolites, as described by Chien et al. (2012), we
incubated the HDFs with NS398, a COX-2 inhibitor, and
AA861 (Figure 6k). NS398 did not affect the HO-1 induction
elicited by AA861. We also considered the possibility of HO-1
expression being regulated by LXA4, as previously described
(Nascimento-Silva et al., 2005). The use of an LXA4 receptor
antagonist, BOC-2, did not modify HO-1 induction promoted
by 5-LO inhibition (Figure 6l).
Taken together, our in vivo and in vitro data suggest that the
absence of 5-LO products improve the wound healing process
due, at least in part, to HO-1 upregulation.
DISCUSSION
Nonhealing wounds are difficult to manage and represent an
expensive burden on health-care systems (Sen et al., 2009). In
this context, it is important to understand and develop new
strategies to treat wounds. In this study, we demonstrate that
metabolites derived from the 5-LO pathway impair skin
wound healing in mice. In addition, primary HDF culture
was used to assess the consequences of 5-LO inhibition on
fibroblast physiology.
5-LO / mice showed accelerated skin wound healing
that is in accordance with a previous study that demonstrated
accelerated fracture healing in 5-LO / mice (Manigrasso
and O’Connor, 2010). However, the role of 5-LO products in
the healing process is not fully understood. Norling et al.
(2011) used a murine peritonitis model to show that treatment
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Figure 3. Heme oxygenase-1 (HO-1) contributes to accelerated wound healing in 5-lipoxygenase knockout (5-LO / ) mice. Immunofluorescence reveals an
upregulation of HO-1 in 5-LO / in comparison with wounds in wild-type (WT) mice at (a) day 2 and (b) day 7. Arrows indicate cells expressing HO-1.
Bar¼20mm. Graphs showing the number of positive cells for HO-1 on the wound bed at (c) day 2 and (d) day 7. DAPI, 4’,6-diamidino-2-phenylindole. Three
fields per slide and 4 slides per group were analyzed (total 12 fields per group). *Po0.05. (e) Photos of wounds from 5-LO / mice treated and not treated
with tin protoporphyrin IX (SnPPIX; 30mg). (f) Graph showing that SnPPIX treatment caused a delay in wound healing in 5-LO / mice. *Po0.05. It is
representative of two independent experiments pooled.
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with proresolving and anti-inflammatory mediators derived
from the 5-LO pathway (Rvs and LXA4) decreased neutrophil
influx and improved the keratinocyte migration. Anti-
inflammatory (Rvs and LXA4) or pro-inflammatory (LTs)
5-LO-derived mediators have a critical role in modulating
the inflammatory response (Spite and Serhan, 2010). Wound
healing depends on the inflammatory response and requires
careful regulation. Decreased levels of chemotactic lipid
mediators such as LTB4 in 5-LO
 / animals can explain the
reduction of leukocyte infiltration observed at the wound bed.
The decreased intensity of inflammatory response in 5-LO /
mice likely allows an earlier initiation of the resolution phase.
Although wound healing was accelerated in 5-LO /
mice, by day 14, wounds in both groups were completely
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Figure 4. The 5-lipoxygenase (5-LO) pharmacological inhibition altered human dermal fibroblast (HDF) functions. HDFs were incubated for 24hours with
AA861 (100mM) and then their functions were assessed. Proliferation rates were assessed by EdU incorporation detected by flow cytometry. (a) Representative
histograms and (b) graph showing proliferation inhibited by AA861 (*Po0.05). Migration was assessed by in vitro wound assay. (c) Images representative of
scratched area. (d) The number of migrated cells was decreased by AA861 (*Po0.05). The graphs represent the mean±SEM of three independent experiments.
Unaltered fibronectin production was assessed by (e) immunofluorescence and confirmed by (f) western blotting. Immunofluorescence for (g) transforming growth
factor-bI (TGF-bI) and (h) TGF-bIII reveals unaltered expression of these proteins. (i) Western blotting for a-smooth muscle actin (a-SMA). *Po0.05 compared to
indicated group. M, medium; V, vehicle.
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healed. Wound-edge contraction reflects the contractile
actions of myofibroblasts (fibroblasts expressing a-SMA). The
differentiation of fibroblasts to myofibroblasts occurs mainly in
the proliferative phase of the normal wound healing process
when the inflammatory phase is downregulated. We showed
that a-SMA is equally expressed in both mouse strains at
day 7 that partially explains why both groups would be
completely healed at day 14, despite significant early differ-
ences between 5-LO / and WT mice.
Considering that fibroblasts are indispensable for the wound
healing process, we used HDFs to study the consequences of
5-LO inhibition. In contrast to the accelerated wound healing
observed in 5-LO / mice, we found reduced migration and
proliferation in HDFs after 5-LO inhibition. In addition, we
observed that pharmacological 5-LO inhibition led to signifi-
cant reduction of ROS formation. Some studies demonstrated
that ROS promotes vascular cell adhesion and migration
(Cook-Mills et al., 2011; Hurd et al., 2012). It is also well
established that ROS can modulate several cell signaling
pathways controlling cell proliferation and survival, antioxidant
response, DNA damage responses, and iron homeostasis
(Ray et al., 2012). Phosphoinositide 3-kinase is regulated by
ROS and it has a key role in cell proliferation and survival in
response to stimulation by growth factors, hormones, and
cytokines (Ray et al., 2012). One possible explanation for
inhibition of fibroblast migration and proliferation observed
in vitro could be because of HO-1 overexpression induced by
5-LO inhibition that in turn can be expected to inhibit free-
radical production. Data in the literature support the
importance of free radicals during fibroblast migration and
proliferation (Wach et al., 1987; Hui, 2008; Yu et al., 2012).
This fact is reinforced by the data in which the 5-LO / mice
treated with SnPPIX, an HO-1 inhibitor, showed delayed
wound healing, suggesting the important role of this anti-
oxidant and anti-inflammatory enzyme for the wound healing.
Wound healing in vivo is influenced by dynamic interac-
tions between the extracellular matrix, growth factors, and
cells. The extracellular matrix works in conjunction with the
entire cellular microenvironment to determine cellular
phenotype and behavior (Schultz et al., 2011). An example
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of growth factor regulation of extracellular matrix occurs
early in the wound healing process, where release of the
platelet-derived growth factor at the wound site acts as a
chemoattractant for fibroblasts, leading to increased collagen
deposition (Grotendorst et al., 1985). Besides the dynamism of
extracellular matrix, it is important to consider other mole-
cules present in the wound microenvironment (e.g., cytokines/
chemokines and eicosanoids). Thus, HDF behavior in culture
conditions may be helpful to understand mechanisms but does
not necessarily translate or correlate with the in vivo events.
HO-1 is expressed in human skin cells and is upregulated
by UVA-1 radiation, playing a protective role (Xiang et al.,
2011). In diabetic ischemic wounds, the combination of
HO-1-overexpressing bone marrow stem cells and collagen
biomaterials significantly promote angiogenesis and wound
healing (Hou et al., 2013). These studies showed beneficial
aspects of HO-1 overexpression in different skin pathologies.
Grochot-Przeczek et al. (2009) demonstrated that wound
healing is impaired in HO-1 / mice and it was reversed
when HO-1 transgene is restored by adenoviral vectors.
Herein, HO-1 overexpression in 5-LO / animals was
correlated with wound healing improvement. We showed
beneficial effects of HO-1 induction by inhibiting 5-LO.
However, alterations in matrix protein deposition, effects of
lipoxin A4– or COX-2-derived mediators, or SOD-2 or Nrf2
expression do not explain these benefits. Thus, the molecular
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mechanism involved in HO-1 upregulation is under
investigation.
The concept of therapies modulating oxidative stress control
is well accepted. For example, N-acetylcysteine, an anti-
oxidant drug, is recognized to improve wound healing in an
excisional wound model in diabetic mice (Aktunc et al.,
2010). Understanding the mechanisms involved in the
antioxidant response by HO-1 induction due to 5-LO
inhibition may help in developing new strategies to treat
nonhealing wounds.
MATERIALS AND METHODS
Mice
5-LO / and SV129 (WT) male mice weighing 25g were obtained
from Fundac¸a˜o Oswaldo Cruz Animal Facility (Fiocruz, Rio de
Janeiro, Brazil) and were used to perform the full-thickness excisional
wound model. The animals were kept at a constant temperature
(25 1C) and a 12-hour light/dark cycle with free access to food and
water. All experiments were conducted in accordance with the
ethical guidelines of, and approved by, the Institutional Animal Care
Committee in the Biomedical Science Institute of the Federal
University of Rio de Janeiro, Brazil, protocol code: DFBCICB028.
Full-thickness excisional wound model
Full-thickness excision wounds were performed as described
previously (Wong et al., 2011). Briefly, mice were anesthetized
with ketamine (112.5mgkg 1, intraperitoneally) and xylazine
(7.5mgkg 1, intraperitoneally), their dorsal surface was shaved and
cleaned with ethanol 70%, and then a full-thickness excision wound
was made with a 10-mm punch biopsy. In one experiment, mice
were treated daily with SnPPIX (Porphyrin Products, Logan, UT)
topically (7 doses, 30mg per wound). The wounds were covered with
sterile transparent film (LM Farma, Sa˜o Jose´ dos Campos, Brazil).
Wounds were kept uncovered after day 7. At days 2 and 7, mice were
killed by an overdose of anesthesia followed by cervical dislocation,
and wounds were collected.
Wound areas were measured at days 0, 4, 7, and 14. Digital images
were obtained at a distance of 5 cm from the wounds, and the ImageJ
software (http://rsb.info.nih.gov/ij/) was used to calculate wound area.
Areas obtained at day 0 were considered 100%. The graphs represent
the median with range of all animals analyzed in each group.
Histological procedures
Tissue samples were fixed in 10% buffered formalin (Sigma Aldrich,
St Louis, MO) and embedded in paraffin. Then, 5mm-thick slices were
prepared for hematoxylin and eosin staining, picrosirius staining, and
immunostaining.
Briefly, selected sections were deparaffinized, rehydrated, and
rinsed with Tris-buffered saline with 0.1% tween (TBS-T) for
5minutes, three times. Antigen retrieval was performed by incubating
the slides for 15minutes in heated citrate buffer (Abcam, Cambridge,
MA). Endogenous peroxidase activity was blocked with 3% H2O2 in
water for 10minutes. After washing in TBS-T, nonspecific binding
was blocked with normal goat serum (Vector Laboratories,
Burlingame, CA) for 1 hour. Sections were incubated overnight at
4 1C with rabbit anti-mouse HO-1 (Enzo Life Sciences, Farmingdale,
NY) or mouse anti-mouse a-SMA (Abcam). Antigen–antibody binding
was visualized using the secondary antibodies bound with fluorophores
(goat anti-rabbit Alexa Fluor 488 or goat anti-mouse Alexa Fluor 647;
Life Technologies, Carlsbad, CA). Slides were covered with mounting
media with 4’,6-diamidino-2-phenylindole (DAPI; Invitrogen,
Carlsbad, CA).
Picrosirius staining was performed according to the manufacturer’s
procedures (Polysciences, Warrington, PA). Slides were dehydrated,
cleared, and mounted with a permanent mounting medium
(VectaMount, Vector Laboratories).
Digital bright-field and fluorescent images were obtained using a
Nikon (TE2000) inverted microscope coupled with a Q-Imaging Retiga
2000R camera and NIS Elements (Advanced Research version 3.20.01)
software (Nikon Instruments, Melville, NY). The graphs represent the
median with range of mean fluorescence intensity obtained from all
sections analyzed (5 animals per group, 3 sections per animal).
Hydroxyproline assay
Hydroxyproline content of wound tissue was used as a quantitative
index of collagen. Wound hydroxyproline levels were determined
spectrophotometrically by absorbance at 550nm, as previously
reported, and the results were expressed as ng of hydroxyproline
per mg of wound tissue (Martins et al., 2009).
HDF primary culture
HDFs were obtained from tissue specimens from healthy young
patients undergoing routine plastic surgery under an institutional
review board–approved protocol. Primary cultures were isolated by a
combination of mechanical disaggregation and enzymatic digestion.
Skin was decontaminated in a solution containing penicillin, strepto-
mycin, and gentamicin (10mgml 1), followed by 0.1% dispase
solution incubation overnight at 4 1C. Dermis was mechanically
separated from the epidermis, cut into small pieces, and incubated
for 1 hour at 5% CO2 and 37 1C with a cell detachment solution
composed of proteases, collagenase, and DNase (Accumax, Innova-
tive Cell Technologies, San Diego, CA). Cells were centrifuged and
transferred into a poly-D-lysine–coated flask. Cells were frozen and
stored in liquid nitrogen. Experiments were performed between the
second and sixth passage.
Reagents
HDFs were treated with AA861 and BOC-2 dissolved in ethanol
(10mgml 1), and MK886 (32mgml 1) and NS398 (5mgml 1)
dissolved in DMSO, and then diluted in DMEM 10% fetal bovine
serum at desired concentrations (Sigma Aldrich).
Hyperbaric stimuli and ROS quantification
Following incubation with AA861 (100mM) for 24hours in six-well
plates, cells were incubated for 1hour in a hyperbaric chamber
(hyperbaric oxygen) designed for tissue culture with 100% O2 at 2.4
atm at 37 1C. Immediately after hyperbaric oxygen chamber, the cells
were incubated with dihydroethidium (Invitrogen Molecular Probes,
Eugene, OR) 2.5mM for 30minutes at 37 1C. Cells were washed with
Hank’s solution (HBSS Invitrogen Molecular Probes). For ROS
quantification, the absorbance was measured at 570nm. Results are
expressed as relative fluorescent units.
Immunocytochemistry
HDFs were incubated with AA861 (100mM) or vehicle for 24hours,
washed with phosphate-buffered saline, fixed in 4% paraformaldehyde
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(Sigma-Aldrich) for 15minutes, and washed in phosphate-buffered
saline. Cells were blocked with 3% BSA for 1 hour at 25 1C, and
incubated with the following primary antibodies: rabbit anti-trans-
forming growth factor-bIII (Abcam), mouse anti-transforming growth
factor-bI (Abcam), rabbit anti-HO-1 (Enzo Lifesciences), and mouse
anti-fibronectin antibody (Abcam). After washing, cells were incu-
bated with goat anti-rabbit Alexa Fluor 488 or goat anti-mouse Alexa
Fluor 647 (Life Technologies) at 25 1C for 1hour. We used mounting
media with DAPI for nuclear staining. Fluorescent images of the cells
were obtained using a Nikon inverted microscope coupled with a
Q-Imaging Retiga 2000R camera and NIS Elements software.
Proliferation assay
HDF proliferation was determined by using the Click-iTEdU cell
proliferation assay (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. Following incubation with AA861
(100mM)þ EdU for 24hours, proliferating cells were labeled with
Alexa Fluor 488 and analyzed using a flow cytometer (Accuri,
BD Accuri C6, BD Biosciences, San Jose, CA). In each sample,
10,000 events were analyzed. The result is the percentage of
proliferating cells.
Scratch assay
To study the fibroblast migration in vitro, we used an established
in vitro wound healing model (Grochot-Przeczek et al., 2009).
Briefly, fibroblasts were seeded onto six-well plates (poly-D-lysine
coated, Thermo Scientific, Madison, WI) and grown until 90%
confluence. Cells were incubated with mitomycin (10mgml 1) for
2 hours to avoid proliferation. Cell-free areas were created by
disrupting the monolayers (scratch) with sterile instruments in a
standardized manner. Subsequently, medium was changed and
cells were incubated with AA861 (100mM). Pictures of the scrat-
ched area were taken immediately after wounding and then returned
to the incubator. After 18hours of incubation, cells were stained with
DAPI and photographed again. Migrated cells were counted based on
DAPI-stained cells in the scratched area. Results are expressed as the
number of cells in the scratched area.
Immunoblotting
After 24hours of incubation with AA861 (100mM), cell lysates were
obtained using lysis buffer (10mM Tris-HCl, pH 7.4, 150mM NaCl,
1% Triton X-100, 2mM PMSF) and a protease inhibitor cocktail
(Pierce, Rockford, IL) and sonicated briefly. Following centrifugation
at 14,000 g for 15minutes, the supernatant was separated and assayed
for protein content by using the Pierce BSA protein assay kit (Pierce).
Cell lysates were stored at  80 1C. Lysates were thawed, mixed with
4 Laemmli sample buffer (0.5M Tris-HCL, pH 6.8, 4% w/v SDS,
20% v/v glycerol, 0.2% w/v bromophenol blue, and 2-mercaptoetha-
nol), boiled for 3minutes, loaded (10mg per lane) onto 12% SDS gels
(Pierce), and transferred to nitrocellulose membrane (Whatman,
Dassel, Germany). Membranes were blocked for 1 hour in 5% skim
milk powder (in TBS-T, pH 7.5), rinsed in TBS-T, and incubated
overnight at 4 1C with either 1:1,000 diluted rabbit anti-HO-1 (Enzo
Lifesciences), 1:3,000 rabbit anti-MnSOD (SOD-2, Abcam), 1:1,000
mouse anti-a-SMA (Abcam), 1:500 mouse anti-fibronectin (Abcam),
1:800 rabbit anti-pNrf2 (Abcam), or 1:1,000 rabbit anti-Nrf2 (Abcam).
The next day, membranes were washed in TBS-T and incubated
for 1 hour at 25 1C with the secondary horseradish peroxidase–
conjugated IgG (Hþ L). Bands were visualized with Pierce ECL
Western Blotting Substrate (Pierce) and Kodak BioMax Light film
(Carestream Health, Rochester, NY). Densitometries of bands were
determined using the ImageJ software and normalized by pan-
actin (housekeeping). Data are expressed as relative quantities
(mean±SEM).
Statistical analysis
Comparisons of numerical data between unpaired conditions
(in vivo experiments) were performed using the nonparametric
Mann–Whitney U-test. All column graphs with data obtained with
animals represent median with range. Student’s t-test was applied for
comparison between paired conditions (in vitro experiments). All
column graphs obtained with cell culture represent mean±SEM.
The P-values of o0.05 were considered to be statistically significant.
All statistical analyses were made with the GraphPad Software (San
Diego, CA).
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